The clinical development of p53-reactivating drugs in sarcomas - charting future therapeutic approaches and understanding the clinical molecular toxicology of Nutlins

Author(s):
Biswas, S.; Killick, E.; Jochemsen, A.G. (0000-0002-0570-7967); Lunec, J.
Published
2014
Publication type
Article / Letter to editor
biomarkersgerm line p53-associated sarcomashuman double minute 2p53sarcomasmall-molecule therapeutics
Date issued
2014-05-31
Language
English
Is part of
hdl
1887/104857
doi
10.1517/13543784.2014.892924